Certara, Inc. (CERT) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 37 days, typically, give or take 10 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 5, 2026before open 36 8-K
Q2 FY2026Tue, Aug 4, 2026before open 35 8-K
Q1 FY2026Mon, May 11, 2026before open 41 8-K
Q4 FY2025Thu, Feb 26, 2026before open 57 8-K
Q3 FY2025Thu, Nov 6, 2025after close 37 8-K
Q2 FY2025Wed, Aug 6, 2025after close 37 8-K
Q1 FY2025Mon, May 5, 2025after close 35 8-K
Q4 FY2024Wed, Feb 26, 2025after close 57 8-K

What they guided beta

Q3 FY2026 "Document Exhibit 99.1 Certara Reports Third Quarter 2026 Financial Results Certara delivers a solid quarter with double-digit software revenue growth Updates 2026 financial outlook Appoints Grant Peterson Chief Product Officer Company to host conference call and webcast today at 8:30 a.m. ET RADNOR, PA — November 5, 2026 -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its third quarter 2026 financial results." exhibit
Q3 FY2026 "See note (2) in the section titled “A Note on Non-GAAP Financial Measures” below for more information on adjusted net income and adjusted diluted earnings per share. 3 THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, 2026 2025 2026 2025 Key Financials (in millions, except per share data) Revenue $ 94.9 $ 90.9 $ 282.3 $ 275.3 Software revenue $ 48.8 $ 43.8 $ 147.4 $ 136.9 Services revenue $ 46.1 $ 47.1 $ 134.9 $ 138.4 Total bookings $ 92.5 $ 88.6 $ 288.0 $ 284.4 Software bookings $ 46.9 $ 40.8 $ 146.3 $ 128.1 Services bookings $ 45.6 $ 47.8 $ 141.6 $ 156.2 Net income (loss) fro" exhibit
Q3 FY2026 "Adjusted EBITDA Margin: The Company's previously communicated full-year 2026 adjusted EBITDA margin outlook was 29% to 31%." exhibit
Q3 FY2026 "Adjusted Diluted Earnings Per Share: The Company is updating its expected full-year adjusted diluted earnings per share range to $0.31 to $0.34." exhibit
Q3 FY2026 "The outlook reflects continuing operations and excludes the Regulatory and Medical Writing business, which was divested on May 8, 2026, and is reported as discontinued operations." exhibit
Q2 FY2026 "Document Exhibit 99.1 Certara Reports Second Quarter 2026 Financial Results A ppoints Julien Perrier Chief Commercial Officer Completes previously authorized $100 million share repurchase program; Board authorizes additional $50 million under repurchase program Reaffirms 2026 revenue guidance RADNOR, PA — August 4, 2026 -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its second quarter 2026 financial results." exhibit
Q2 FY2026 "“We continue to expect full-year revenue growth of 0% to 4% on a comparable continuing operations basis, supported by continued strength in software and improving services performance as we move through the second half of the year.”" exhibit
Q2 FY2026 "THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, 2026 2025 2026 2025 Key Financials (in millions, except per share data) Revenue $ 93.3 $ 92.4 $ 187.4 $ 184.5 Software revenue $ 48.8 $ 46.7 $ 98.5 $ 93.1 Service revenue $ 44.5 $ 45.7 $ 88.8 $ 91.4 Total bookings $ 98.3 $ 97.4 $ 195.5 $ 195.7 Software bookings $ 50.7 $ 46.6 $ 99.4 $ 87.3 Services bookings $ 47.6 $ 50.8 $ 96.1 $ 108.4 Net income (loss) $ (6.1) $ 1.5 $ (17.9) $ 3.0 Diluted earnings (loss) per share $ (0.04) $ 0.01 $ (0.11) $ 0.02 Adjusted EBITDA $ 26.2 $ 27.0 $ 52.9 $ 55.4 Adjusted net income $ 12.5 $ 12.7 $ 21.6 $ 29.5 Adju" exhibit
Q2 FY2026 "Full year 2026 adjusted EBITDA margin for Continuing Operations, excluding the Regulatory and Medical writing business, is expected to be approximately 29% to 31%." exhibit
Q2 FY2026 "Full year adjusted diluted earnings per share for Continuing Operations, excluding the Regulatory and Medical Writing business is expected to be in the range of $0.31 to $0.36." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CERT
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CERT

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

CERT earnings date badge

HTML

<a href="https://veritasdata.dev/company/CERT/"><img src="https://veritasdata.dev/embed/CERT.svg" alt="CERT earnings date" width="240" height="56"></a>

Markdown

[![CERT earnings date](https://veritasdata.dev/embed/CERT.svg)](https://veritasdata.dev/company/CERT/)

Script

<script async src="https://veritasdata.dev/embed/CERT.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CERT"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.